Table 2. Pharmacokinetics data in mice treated with pyronaridine.
Cmax (ng/ml) |
AUClast (h*ng/ml) |
||||||||
---|---|---|---|---|---|---|---|---|---|
Dose (mg/kg) |
Sex | T1/2 (h) | SE | Tmax (h) | Mean | SE | Mean | SE | AUCinf (h*ng/ml) |
5 | M | NC | 0.25 | 44.4 | 9.58 | 192 | 12.2 | NC | |
5 | F | NC | 0.083 | 54 | 2.44 | 257 | 13.5 | NC | |
25 | M | NC | 0.25 | 115 | 19.3 | 713 | 34.2 | NC | |
25 | F | NC | 0.25 | 160 | 41.4 | 956 | 45.5 | NC | |
75 | M | 146 | 12.7 | 1.† | 982 | 242 | 33039 | 4731 | 33912 |